In Brief: OTC label study
This article was originally published in The Tan Sheet
Executive Summary
OTC label study: Results from FDA's "Evaluation of Proposed OTC Label Format Comprehension," referred to as "Study A," are posted on the agency's Web site (www.fda.gov). The 1,200 subject, mall-intercept study tested consumers' understanding and impression of mock OTC cough/cold and pain reliever labels. Participants viewed labels representative of both the current style and the "new" format outlined in FDA's Feb. 27 proposed rule on OTC label reform. FDA published an availability notice for its OTC Label Format Preference (Study B) in the Dec. 30 Federal Register ("The Tan Sheet" Jan. 12, pp. 3-5). The agency described plans for the studies in May ("The Tan Sheet" May 26, 1997, p. 1). FDA will use the results of the studies in preparing its final rule on OTC labeling...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning